HIKMA PHARMACEUTICALS revenue breakdown overview

HIKMA PHARMACEUTICALS revenue for the last year amounted to 65.80 B MXN, the most of which — 26.66 B MXN — came from its highest performing source at the moment, Injectables, the year earlier bringing 20.93 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought HIKMA PHARMACEUTICALS 38.52 B MXN, and the year before that — 30.02 B MXN.